Vacancy of Product Management Executive in Torrent Pharma at Ahmedabad. Thursday, December 3, 2020. WARNING LETTER CMS #584701. October 28, 2019 Dear Mr. Food and Drug Administration (FDA) inspected your drug manufacturing facility, Torrent Pharma. Torrent Pharmaceuticals follows the tradition of Dedication, Professional Integrity and Robust R&D in the pursuit of excellence. With leading brands in various therapeutic segments, our products have proved to be efficient and effective in areas of Cardiovascular, CNS, Gastro-Intestinal, Diabetology, Anti-Infective, VMN and Pain Management solutions. Torrent Pharma (UK) Ltd is one of the fastest growing generic pharmaceutical companies within the UK; the most mature generics market in Western Europe. Through robust supplies from Torrent Pharmaceuticals and several portfolio acquisition deals, we have built a robust pipeline of products and a current range of over 100 molecules.
Torrent Pharma’s API unit is a multi-product facility, with a capacity to manufacture Advance Intermediates & Active Pharmaceutical Ingredients (APIs). The acquired Plant enabled Torrent in backward integration and scale up our manufacturing capacity to meet the growing demand from the international markets.
INFRASTRUCTURE
- Total Area: 21,159 sq. meters
- Total Built Up Area: 11,708 sq. meters
- Commercial Plant : - no of reactor: 70; Pilot Plant: 4
- 4 Pharma blocks and 1 Pilot plant to manufacture 5 APIs at a time
CAPACITY
- 20-25 MT
APPROVALS
Torrent Pharma Product Portfolio Samples
.jpg?auto=format%2Ccompress&w=400&dpr=2.6 "Torrent")
Tris Pharma Products
- EU GMP
- USFDA
- Korean FDA
- EDQM (CEP)
- EDQM (GMP)
- COFFEPRIS –Mexican Health Authority
Torrent Pharmaceuticals Products
- Total Land : 21,159 sq. meters
- API Capacity: 20-25 MT